developed CD4-CAR-T cells to treat peripheral T-cell lymphomas but encountered significant fratricide, resulting in the enrichment of CD4+ CD8+ CD4-CAR-T cells. The gene discussed is CD4; the disease is T-cell non-Hodgkin lymphoma.